Ambryon Biosciences

Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy

Russell et al. (2017). LancetResearch

Described parts & designs

Identifiers & revision